The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Radio Frequency Identification (RFID) In Pharmaceuticals Market By 2030 Starting From Its 2026 Size?

The market for radio frequency identification (RFID) in pharmaceuticals has experienced rapid expansion in recent years. This market is projected to expand from $6.08 billion in 2025 to $6.74 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.9%. Historically, this growth can be ascribed to several factors, including an increasing regulatory focus on drug traceability, a rise in incidents of counterfeit medicines, the expansion of global pharmaceutical supply chains, the adoption of serialization mandates, and the growing complexity of hospital inventory.

The radio frequency identification (rfid) in pharmaceuticals market is projected to experience substantial expansion in the coming years. It is anticipated to reach $10.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period is fueled by increasing investments in digital pharmaceutical logistics, a rising demand for real-time supply chain visibility, the expansion of rfid-enabled smart hospitals, growing adoption of blockchain-linked traceability systems, and increasing regulatory harmonization across regions. Significant trends expected during this period include the wider adoption of end-to-end drug track and trace systems, increased use of rfid for anti-counterfeiting measures, deeper integration of rfid with serialization platforms, expanded real-time pharmaceutical inventory visibility, and an enhanced focus on the accuracy of cold chain monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25891&type=smp

What Primary Drivers Are Shaping The Development Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

The rising occurrences of counterfeit drugs are projected to fuel the expansion of the radio frequency identification (RFID) in pharmaceuticals market in the future. Counterfeit drugs, sometimes referred to as fake medicines, are pharmaceutical items intentionally and deceitfully mislabeled concerning their identity or origin. The escalation in counterfeit drug cases stems from the quick rise of online pharmacies, which has facilitated counterfeiters in supplying fraudulent medications directly to consumers, circumventing established regulatory protections and complicating discovery. Radio frequency identification (RFID) in pharmaceuticals aids in combating fake drugs by offering secure, verifiable information that confirms product genuineness throughout the entire supply chain. For example, in December 2024, the American Chemical Society, a US-based nonprofit scientific society, reported 6,987 counterfeit drug incidents across 142 countries in 2023, marking a 4% rise from 2022. Consequently, the growing frequency of counterfeit drugs is stimulating the development of the radio frequency identification (RFID) in pharmaceuticals market.

Which Segment Categories Define The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

The radio frequency identification (rfid) in pharmaceuticals market covered in this report is segmented –

1) By Type: Chipped Radio Frequency Identification, Chipless Radio Frequency Identification

2) By Component: Radio Frequency Identification Tags, Radio Frequency Identification Readers, Middleware Software, Integration Services, Data Management Software

3) By Regulatory Compliance: Food And Drug Administration Compliance Standards, European Union Falsified Medicines Directive, Good Distribution Practices, Serialization Requirements, Tracking And Tracing Regulations

4) By Application: Drug Track And Trace System, Asset Tracking, Patient Safety, Other Applications

5) By End-User: Pharmaceutical Manufacturers, Hospitals And Healthcare Providers, Pharmacies And Drug Wholesalers, Research And Development Laboratories, Logistics And Supply Chain Companies

Subsegments:

1) By Chipped Radio Frequency Identification: Low Frequency Radio Frequency Identification, High Frequency Radio Frequency Identification, Ultra High Frequency Radio Frequency Identification, Active Radio Frequency Identification, Passive Radio Frequency Identification, Semi-Passive Radio Frequency Identification

2) By Chipless Radio Frequency Identification: Time Domain Reflectometry, Frequency Domain Reflectometry, Magnetic Resonance-Based Tags, Surface Acoustic Wave Tags, Printed Conductive Polymer Tags, Photonic Band Gap Structures

What Key Developments And Trends Are Impacting The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

In the radio frequency identification (RFID) in pharmaceuticals market, leading companies are dedicating efforts to creating sophisticated RFID-enabled labels. This initiative aims to improve product traceability, enhance inventory management, and counter the growing risk of counterfeit drugs. RFID-enabled labels are intelligent tags that leverage radio frequency technology to wirelessly identify, track, and authenticate pharmaceutical items throughout their supply chain. As an illustration, in May 2023, Fresenius Kabi AG, a pharmaceutical company based in Germany, launched its Rocuronium Bromide Injection, which incorporates advanced RFID-enabled labeling to boost medication tracking, inventory control, and patient safety within healthcare facilities. The injection is provided as a 50 mg per 5 mL multiple-dose vial intended for intravenous administration by qualified medical personnel. Its advanced RFID-enabled smart labeling facilitates real-time tracking, optimizes inventory procedures, and aids in minimizing medication errors.

Who Are The Top Companies Competing In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Major companies operating in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, identytag GmbH & Co KG

Read the full radio frequency identification (rfid) in pharmaceuticals market report here:

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-in-pharmaceuticals-global-market-report

How Does The Radio Frequency Identification (RFID) In Pharmaceuticals Market Perform Across Major Global Regions?

North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radio frequency identification (rfid) in pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Radio Frequency Identification (RFID) In Pharmaceuticals Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25891&type=smp

Browse Through More Reports Similar to the Global Radio Frequency Identification (RFID) In Pharmaceuticals Market 2026, By The Business Research Company

Medical Irradiation Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Radiotherapy Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Single Dose Radiotherapy Services Global Market Report

https://www.thebusinessresearchcompany.com/report/single-dose-radiotherapy-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model